EFANESOCTOCOG ALFA for Factor viii deficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 292 adverse event reports in the FDA FAERS database where EFANESOCTOCOG ALFA was used for Factor viii deficiency.
Most Reported Side Effects for EFANESOCTOCOG ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 201 | 32.3% | 0 | 20 |
| Traumatic haemorrhage | 55 | 8.8% | 0 | 4 |
| Arthralgia | 45 | 7.2% | 0 | 5 |
| Fall | 35 | 5.6% | 0 | 3 |
| Haemarthrosis | 29 | 4.7% | 0 | 7 |
| Joint injury | 29 | 4.7% | 0 | 0 |
| Limb injury | 29 | 4.7% | 0 | 4 |
| Inappropriate schedule of product administration | 24 | 3.9% | 0 | 3 |
| Contusion | 23 | 3.7% | 0 | 3 |
| Epistaxis | 23 | 3.7% | 0 | 1 |
| Dizziness | 20 | 3.2% | 0 | 2 |
| Dyspnoea | 19 | 3.1% | 0 | 3 |
| Headache | 18 | 2.9% | 0 | 4 |
| Joint swelling | 17 | 2.7% | 0 | 2 |
| Head injury | 16 | 2.6% | 0 | 0 |
Other Indications for EFANESOCTOCOG ALFA
Haemorrhage prophylaxis (42)
Haemorrhage (33)
Prophylaxis (19)
Haemophilia (14)
Product used for unknown indication (10)
Other Drugs Used for Factor viii deficiency
EMICIZUMAB-KXWH (6,532)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268)
EFMOROCTOCOG ALFA (832)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352)
ANTI-INHIBITOR COAGULANT COMPLEX (317)
EMICIZUMAB (315)
DAMOCTOCOG ALFA PEGOL (310)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)
ANTIHEMOPHILIC FACTOR HUMAN (161)